Lynx1 Capital Management LP
SEC insider (Form 3/4/5 filer). CIK 0001910456. 10% Owner at Korro Bio, Inc. (KRRO) and 4 other issuers. 32 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in DORADO.
Companies Lynx1 Capital Management LP has filed insider reports for
- Korro Bio, Inc. (KRRO): 10% Owner
- Passage BIO, Inc. (PASG): 10% Owner
- TScan Therapeutics, Inc. (TCRX): 10% Owner
- Cullinan Therapeutics, Inc. (CGEM): 10% Owner
- Neuphoria Therapeutics Inc. (NEUP): 10% Owner
Lynx1 Capital Management LP
CIK: 0001910456
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Aug 10, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect1.5K shares at avg. $13.19$19K - Aug 6, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect5.2K shares at avg. $11.40$60K - Jun 25, 2026PASG
Passage BIO, Inc.
PurchaseIndirect50.1K shares at avg. $4.12$206K - Mar 31, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect520 shares at avg. $10.60$6K - Dec 23, 2025TCRX
TScan Therapeutics, Inc.
PurchaseIndirect6.2K shares at avg. $0.90$6K - Dec 22, 2025TCRX
TScan Therapeutics, Inc.
PurchaseIndirect75.5K shares at avg. $0.90$68K - Dec 19, 2025TCRX
TScan Therapeutics, Inc.
PurchaseIndirect80.1K shares at avg. $0.90$72K - Oct 28, 2025CGEM
Cullinan Therapeutics, Inc.
PurchaseIndirect165.7K shares at avg. $8.40$1.4M - Oct 21, 2025NEUP
Neuphoria Therapeutics Inc.
PurchaseIndirect639.1K shares at avg. $5.14$3.3M - Oct 17, 2025CGEM
Cullinan Therapeutics, Inc.
PurchaseIndirect32.2K shares at avg. $7.84$253K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  KRRO Korro Bio, Inc. | Purchase | 1,462 | $13.19 | $19,279 | Indirect |
| Aug 6, 2026 | KRRO Korro Bio, Inc. | Purchase | 5,222 | $11.40 | $59,530 | Indirect |
| Jun 25, 2026 |  PASG Passage BIO, Inc. | Purchase | 50,055 | $4.12 | $206,101 | Indirect |
| Mar 31, 2026 | KRRO Korro Bio, Inc. | Purchase | 520 | $10.60 | $5,512 | Indirect |
| Dec 23, 2025 |  TCRX TScan Therapeutics, Inc. | Purchase | 6,232 | $0.90 | $5,602 | Indirect |
| Dec 22, 2025 | TCRX TScan Therapeutics, Inc. | Purchase | 75,500 | $0.90 | $67,950 | Indirect |
| Dec 19, 2025 | TCRX TScan Therapeutics, Inc. | Purchase | 80,069 | $0.90 | $71,974 | Indirect |
| Oct 28, 2025 |  CGEM Cullinan Therapeutics, Inc. | Purchase | 165,667 | $8.40 | $1,391,686 | Indirect |
| Oct 21, 2025 |  NEUP Neuphoria Therapeutics Inc. | Purchase | 639,110 | $5.14 | $3,283,108 | Indirect |
| Oct 17, 2025 | CGEM Cullinan Therapeutics, Inc. | Purchase | 32,217 | $7.84 | $252,565 | Indirect |
1-10 of 32 transactions